日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection.

感染普马拉病毒后,会产生能够中和多种汉坦病毒的交叉结合抗体。

Clark Jordan J, Hatzl Stefan, Vasilev Kirill, Andreata-Santos Robert, Yong Jeremy S, Mittler Eva, Kasikci Ezgi, Chandran Kartik, Simon Viviana, Krause Robert, Krammer Florian

Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis

XBB.1.5 COVID-19 单价疫苗的人类单克隆抗体反应图谱:B 细胞分析

Fantin, Raianna F; Clark, Jordan J; Cohn, Hallie; Jaiswal, Deepika; Bozarth, Bailey; Rao, Vishal; Civljak, Alesandro; Lobo, Igor; Nardulli, Jessica R; Srivastava, Komal; Yong, Jeremy S; Andreata-Santos, Robert; Bushfield, Kaitlyn; Lee, Edward S; Singh, Gagandeep; Kleinstein, Steven H; Krammer, Florian; Simon, Viviana; Bajic, Goran; Coelho, Camila H

Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1.

用 TLR 激动剂佐剂的祖先 SARS-CoV-2 刺突蛋白进行疫苗接种可提供针对 XBB.1 的交叉保护

Lathrop Stephanie K, Clark Jordan J, Siram Karthik, Andreata-Santos Robert, Yong Jeremy, Tee Rebekah D, Davison Clara J, Singh Gagandeep, Burkhart David, Krammer Florian, Evans Jay T